Dr. Daniel Ehud Spivack, MD

Dr. Spivack practices at Kaiser Permanente Woodland Hills Medical Center in Woodland Hills, California, part of Kaiser Permanente.

Dr. Spivack's NPI, 1184888109, was assigned on July 18, 2008. Dr. Spivack graduated from The Flinders University of South Australia School of Medicine in 2001. Dr. Spivack's Pennsylvania license number on file is MT182722.

Dr. Spivack's primary practice is Kaiser Permanente Woodland Hills Medical Center, at 5601 De Soto Avenue, Woodland Hills, CA 91367 in Los Angeles County. The practice phone is (818) 719-3800.

Dr. Spivack's primary practice is Kaiser Permanente Woodland Hills Medical Center in Woodland Hills, California, part of Kaiser Permanente. Dr. Spivack is also affiliated with Temple University Hospital. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Spivack to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spivack practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Spivack's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Spivack is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Spivack's licenses on file in 2 states: Pennsylvania and California.

Dmand AI lists varicose veins among the conditions Dr. Spivack treats.

CMS counts 16 Medicare patients who saw Dr. Spivack in 2024. 69% of them have high blood pressure. Their average risk score is 3.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spivack's median patient age at 69, with 61% women.

In 2024, Dr. Spivack wrote 88 Medicare Part D claims for 52 patients. 89% of them were for generic drugs. CMS names the drug for 34 of them, across 1 drug with 11 or more claims each, at $516 in total drug cost. In 2023, CMS named 43 claims across 2 drugs.

Dr. Spivack accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Spivack in 2010. The most frequent topics are Pancreatic Neoplasms, Luminescent Proteins and Mice, Nude. Dr. Spivack has published most often in Cancer Res. Dr. Spivack's most frequent co-authors are Michael Bouvet, MD and Matthew Harold Katz, MD.

CMS Open Payments shows 11 general payments to Dr. Spivack from 6 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $174.

Dmand AI lists 1 award for Dr. Spivack, most recently CMS Stage 1 2012 in 2011.

Dr. Spivack graduated from The Flinders University of South Australia School of Medicine in 2001. Dr. Spivack is a member of SVS.

Dr. Spivack is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.